Stock Report

Download full stock data and analysis for free Last Updated: 27-Aug-2026

Stock Rating

Is this stock worth it? Our ratings reveal the truth.

Wealth Insight New Issue

Serious stock insights. No fluff. No FOMO.

Recently Viewed

Clear All

Titan Bio-Tech Key Ratios

Stock Card factsheet watchlist-stock-modal share-fund-plan-icon

BSE: 524717

₹378.75

up-down-arrow ₹-2.65 (-0.69%)

As on 26-Aug-2026IST

Market cap

info icon

₹1,565 Cr

Revenue (TTM)

info icon

₹219 Cr

P/E Ratio

info icon

46.2

P/B Ratio

info icon

8.2

Div. Yield

info icon

0.1 %

Key Ratios and Highlights

Growth Score (%) Quarterly Annual (TTM)
Particulars QoQ YoY 1-Year 3-Years 5-Years
Revenue 21.16 27.25 36.93 15.04 8.69
EBIT 32.16 46.59 71.97 11.92 -1.44
Net Profit 61.33 58.20 54.03 12.97 4.96
EPS 61.34 58.20 54.04 12.97 5.18
Book Value -- -- 14.95 21.16 31.38
Key Ratios (%) Average Annual (TTM)
Particulars3-Years5-YearsTTMMar-25Mar-24
EBIT-Margin info 17.0521.0917.0013.5918.86
Net Margin info 13.3615.9313.6411.3914.27
Return on equity info 18.4728.0719.4712.7419.45
Return on Capital info 24.0032.87--17.0025.39
Return on Assets info 14.5119.0115.8210.5815.44
Debt to Equity (x) info ----0.000.010.05

Profitability

View Detailed Peer Comparison

ROCE

--

--

Earning before interest and taxes / (Average net worth + Average total Debt) * 100

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Titan Bio-Tech
--
17.00
25.39
27.40
33.74
Peer Median
--
10.67
24.98
20.19
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
ROE

19.47

Higher than Peers by 9.45

Profit after tax / Average Net worth * 100

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Titan Bio-Tech
19.47
12.74
19.45
21.44
27.98
Peer Median
10.02
7.59
20.21
19.34
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
ROA

15.82

Higher than Peers by 9.58

Profit after tax / Average Total assets * 100

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Titan Bio-Tech
15.82
10.58
15.44
16.37
19.16
Peer Median
6.25
5.44
12.91
11.01
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EBIT Margin

17.00

Higher than Peers by 6.44

Operating profit (EBIT) / Net Sales * 100

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Titan Bio-Tech
17.00
13.59
18.86
18.69
23.39
Peer Median
10.56
11.66
11.54
15.47
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Net Margin

13.64

Higher than Peers by 6.16

Net profit / Total Income (Net sales plus other income) * 100

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Titan Bio-Tech
13.64
11.39
14.27
14.41
17.42
Peer Median
7.48
7.57
9.71
10.37
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Cash Profit Margin

--

--

(Net profit + Depreciation) / Gross Sales * 100

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Titan Bio-Tech
--
14.34
16.45
16.41
19.47
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Growth

View Detailed Peer Comparison

Revenue Growth

36.93

Higher than Peers by 32.06

Year on year growth in net sales

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Titan Bio-Tech
36.93
-4.65
13.94
16.55
-13.14
Peer Median
4.88
9.11
-10.85
39.46
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EBIT Growth

71.97

Higher than Peers by 77.05

Year on year growth in operating profit (EBIT)

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Titan Bio-Tech
71.97
-31.32
14.98
-6.86
-34.27
Peer Median
-5.07
6.88
-32.98
80.25
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Net Profit Growth

54.03

Higher than Peers by 53.68

Year on year growth in profit after tax

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Titan Bio-Tech
54.03
-22.79
12.55
-3.04
-31.61
Peer Median
0.35
16.56
-31.20
77.33
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EPS Growth

54.04

Higher than Peers by 56.88

Year on year growth in earnings per share

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Titan Bio-Tech
54.04
-13.36
0.04
14.57
-28.52
Peer Median
-2.85
20.92
--
80.00
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Book Value Growth

--

--

Year on year growth in book value per share

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Titan Bio-Tech
--
14.95
21.42
27.44
25.43
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Solvency

View Detailed Peer Comparison

Debt to Equity

0.00

Lower than Peers by 0.04

Total debt / Net worth

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Titan Bio-Tech
0.00
0.01
0.05
0.06
0.09
Peer Median
0.04
0.07
0.15
0.25
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Short term debt to equity ratio

--

--

(Short term borrowings / Net worth)

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Titan Bio-Tech
--
0.01
0.05
0.05
0.05
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Current Ratio

3.28

Higher than Peers by 1.61

Current Assets / Current Liabilities and Provisions

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Titan Bio-Tech
3.28
3.59
2.94
2.74
2.95
Peer Median
1.68
1.68
1.57
1.55
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Quick Ratio

1.14

Higher than Peers by 0.15

(Current Assets - Inventory) / Current Liabilities and Provisions

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Titan Bio-Tech
1.14
1.45
1.27
1.43
1.51
Peer Median
0.99
1.31
1.19
0.97
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Interest Coverage

47.67

Higher than Peers by 38.16

Earning before interest and taxes (EBIT) / Interest Expenses

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Titan Bio-Tech
47.67
31.39
27.95
38.69
34.22
Peer Median
9.51
7.47
19.21
17.50
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Operating Efficiency

View Detailed Peer Comparison

Debtors to sales

10.43

Lower than Peers by 3.28

Debtors outstanding / Net Sales * 100

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Titan Bio-Tech
10.43
12.03
11.37
14.59
13.24
Peer Median
13.71
14.65
12.34
12.61
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Asset Turnover

1.13

Higher than Peers by 0.35

Sales / Average Total Assets

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Titan Bio-Tech
1.13
0.91
1.07
1.12
1.09
Peer Median
0.78
0.86
0.92
1.17
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Receivable days

--

--

Average Debtors / Sales * 365

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Titan Bio-Tech
--
43.71
44.12
47.36
50.91
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Inventory Days

--

--

Average Inventory / Sales * 365

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Titan Bio-Tech
--
112.33
90.92
89.79
99.29
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Payable days

--

--

Average Creditors / Cost of goods sold * 365

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Titan Bio-Tech
--
21.58
21.53
25.39
24.97
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Cash Conversion Cycle

--

--

Receivable Days + Inventory Days - Payable Days

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Titan Bio-Tech
--
134.47
113.51
111.76
125.23
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Valuation

View Detailed Peer Comparison

Price / Earnings

46.19

Higher than Peers by 17.42

Current share price divided by earning per share in the last twelve months

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Titan Bio-Tech
46.19
16.18
17.56
6.55
9.99
Peer Median
28.77
40.01
28.36
14.07
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Price / Book Value

8.19

Higher than Peers by 6.27

Current share price divided by book value per share in the latest financial year

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Titan Bio-Tech
8.19
2.27
3.27
1.48
2.51
Peer Median
1.92
1.93
2.13
2.38
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Dividend Yield

0.13

Lower than Peers by 0.27

Dividend per share in the past twelve months divided by current share price

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Titan Bio-Tech
0.13
0.47
0.38
0.91
0.57
Peer Median
0.40
0.27
0.45
0.44
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EV/EBITDA

32.07

--

Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Titan Bio-Tech
32.07
11.76
12.22
5.24
6.75
Peer Median
--
22.60
12.16
12.87
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Market Cap

1,565

Lower than Peers by 58

Current Share price multiplied by latest total number of shares outstanding

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Titan Bio-Tech
1,565
348
436
163
217
Peer Median
1,623
1,454
1,457
1,879
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...
loading...
loading...
loading...
loading...